CAS: 495-02-3; (E)-7-((3,7-Dimethylocta-2,6-Dien-1-yl)Oxy)-2H-Chromen-2-One

上下游产品

(R)-6-O-(4-geranyloxy-2-hydroxy)cinnamoylmarmin 7-hydroxy-2H-chromen-2-one 1-chloro-3,7-dimethyl°Cta-2,6-diene(6'R,2'E)-dihydroxy-6',7' dimethyl-3',7' °Ctene-2' oxy-7 coumarine (S)-7-(6,7-dihydroxy-3,7-dimethyl°Ct-2E-enyloxy)chromen-2-one 7-(7-hydroxy-3,7-dimethyl-6-oxo°Ct-2E-enyloxy)chromen-2-one 7-(6,7-dihydroxy-3,7-dimethyl°Ct-2E-enyloxy)chromen-2-one

香叶醇置于三溴化磷,1,8-二氮杂双环[5.4.0]十一碳-7-烯体系中,用 乙醚,N,N-二甲基甲酰胺 作为反应溶剂,化学反应 7.25H,反应生成 橙皮油内酯
参考文献:含单萜的取代香豆素的抗流感活性
标题:含单萜的取代香豆素的抗流感活性
摘要:已经测试了同时带有单萜和香豆素部分的化合物的细胞毒性和对流感病毒a / California / 07/09(h1N1)pdm09的抑制活性.香豆素骨架中取代基的结构,以及单萜类结构部分的结构和绝对构型均显示出显着影响所研究化合物的抗流感活性和细胞毒性.具有双环pin烷骨架的化合物表现出最高的选择性指数(细胞毒性与有效剂量之间的比率).(-)-Myrtenol 15C的衍生物在这类化合物中,其具有有希望的活性,低细胞毒性和可合成的可及性,具有最大的潜力.当在病毒繁殖的早期添加到被感染的细胞培养物中时,它表现出最高的活性.
DOI:10.1016/j.Bmcl.2017.04.091

专利信息

专利号:US-2013224318-A1
优先权日:2012-02-29
标 题 :Use of CPT-1 Modulators and Compositions Thereof
发明人：HWANG CHENG S; YIM SUNGHAN; SANTHANAM UMA; LYGA JOHN W
权利人:AVON PROD INC; AVON PROD INC
摘要:The present invention describes methods for improving the appearance of skin, particularly, treating, ameliorating, preventing, delaying, and/or improving one or more signs of excess accumulation and/or production of subcutaneous fat, such as cellulite, and conditions related thereto, by topically applying compositions comprising Carnitine Palmitoyl Transferase-1 (CPT-1) modulators, optionally with other anti-lipid agents; and also describes compositions and methods for treating, preventing and improving the appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating loss of subcutaneous fat in the skin, wherein the compositions include natural plant constituents that stimulate lipid synthesis.

专利号:US-12036300-B2
优先权日:2021-03-31
标题:Methods and compositions for improving skin
发明人：LIAO I-CHIEN; BRIEVA PATRICIA; JUCHAUX FRANCK; BOUEZ CHARBEL; ZHENG QIAN; QIAN KUN
权利人:OREAL
摘要:A method for managing skin tone comprising reducing the synthesis of melanin by applying a skin treatment composition to skin. The skin treatment composition may include about 0.1 to about 25 wt. % of acetyl trifluoromethylphenyl valylglycine; about 0.5 to about 30 wt. % of a polyol; about 0.1 to about 30 wt. % of a silicone, fatty compound, or a mixtures thereof, wherein the skin treatment composition is an emulsion, and all weight percentages are based on the total weight of the skin treatment composition.

专利号:CN-115197981-A
优先权日:2022-07-12
标题 :Fermentation method for improving synthesis of yellow pigment and orange pigment in monascus purpureus